MedTrace Logo

Genotype-phenotype Association in Hereditary Hemorrhagic Telangiectasia

NCT05550376 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2025-03-17

No results posted yet for this study

Summary

The present project aims to study the inflammatory and endothelial responses involved in the differences in clinical events related to both genotypes (ENG vs. ACVRL1) in HHT. Accordingly, a cross-sectional study is proposed to evaluate the differences in circulating inflammatory and endothelial biomarkers, including interleukines, adhesion molecules, chemokines and immune regulatory molecules between both HHT groups.

Conditions

  • Hereditary Hemorrhagic Telangiectasia
  • HHT
  • Rendu Osler Weber Disease

Interventions

OTHER

Registry

Non-interventional registry

Sponsors & Collaborators

  • Sociedad Española De Medicina Interna

    collaborator OTHER

  • Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

    lead OTHER

Principal Investigators

  • José Luis Patier, MD · Hospital Universitario Ramón y Cajal

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-30
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05550376 on ClinicalTrials.gov